AU7366398A - Methods for eosinophil depletion and compositions therefor - Google Patents
Methods for eosinophil depletion and compositions thereforInfo
- Publication number
- AU7366398A AU7366398A AU73663/98A AU7366398A AU7366398A AU 7366398 A AU7366398 A AU 7366398A AU 73663/98 A AU73663/98 A AU 73663/98A AU 7366398 A AU7366398 A AU 7366398A AU 7366398 A AU7366398 A AU 7366398A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- compositions therefor
- eosinophil depletion
- eosinophil
- depletion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pain & Pain Management (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85221897A | 1997-05-07 | 1997-05-07 | |
US08852218 | 1997-05-07 | ||
PCT/US1998/008974 WO1998050434A1 (en) | 1997-05-07 | 1998-05-01 | Methods for eosinophil depletion and compositions therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7366398A true AU7366398A (en) | 1998-11-27 |
Family
ID=25312766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU73663/98A Abandoned AU7366398A (en) | 1997-05-07 | 1998-05-01 | Methods for eosinophil depletion and compositions therefor |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0981550A1 (en) |
JP (1) | JP2001527410A (en) |
AU (1) | AU7366398A (en) |
CA (1) | CA2288017A1 (en) |
WO (1) | WO1998050434A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5096704A (en) * | 1988-11-03 | 1992-03-17 | Schering Corporation | Method of treating eosinophilia |
WO1997012914A1 (en) * | 1995-10-05 | 1997-04-10 | Shionogi & Co., Ltd. | Novel human cc chemokine |
EP1012190A4 (en) * | 1996-04-26 | 2004-04-28 | Merck & Co Inc | Eosinophil eotaxin receptor |
-
1998
- 1998-05-01 AU AU73663/98A patent/AU7366398A/en not_active Abandoned
- 1998-05-01 JP JP54829698A patent/JP2001527410A/en active Pending
- 1998-05-01 EP EP98920942A patent/EP0981550A1/en not_active Withdrawn
- 1998-05-01 CA CA002288017A patent/CA2288017A1/en not_active Abandoned
- 1998-05-01 WO PCT/US1998/008974 patent/WO1998050434A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2288017A1 (en) | 1998-11-12 |
JP2001527410A (en) | 2001-12-25 |
EP0981550A1 (en) | 2000-03-01 |
WO1998050434A1 (en) | 1998-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9790198A (en) | Compounds and methods | |
HUP0004533A3 (en) | Microorganism reduction methods and compositions for food | |
AU7275098A (en) | Enhanced adenovirus-assisted transfection composition and method | |
AU8693098A (en) | Compositions and methods for treating diabetes | |
AU4261697A (en) | Compounds and methods | |
AUPO976797A0 (en) | Method and composition (III) | |
AU2349399A (en) | R-lansoprazole compositions and methods | |
AU8019598A (en) | Composition and method for providing glutamine | |
AUPO976597A0 (en) | Method and composition (I) | |
AU2330999A (en) | Methods and compositions for enhancing cognitive function using morphogenic proteins | |
AU749278C (en) | Composition for use in dementia | |
AU3200197A (en) | New composition and methods | |
AU9259198A (en) | Holding piece and method for holding containers | |
AUPO982097A0 (en) | Methods and compositions for use therein | |
AU9374498A (en) | Makeup composition and method | |
AU7366398A (en) | Methods for eosinophil depletion and compositions therefor | |
AU5253798A (en) | Ubch7-like ubiquitin-conjugating enzyme | |
AU7287798A (en) | Compositions and methods for bioremediation | |
AU9167698A (en) | Mini-stencil and device for using same | |
AU4408097A (en) | Method and arrangement for receiving messages | |
AU1061200A (en) | Decontamination method and composition therefor | |
AU1453299A (en) | Materials and methods for quantitative pcr | |
GB9605274D0 (en) | An enzyme | |
AU1902999A (en) | Hydrophobically-modified protein compositions and methods | |
AUPO853997A0 (en) | Method and novel compounds for use therein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |